Expert Consensus on the Diagnosis and Treatment of <i>NRG1/2</i> Gene Fusion Solid Tumors
The fusion genes NRG1 and NRG2, members of the epidermal growth factor (EGF) receptor family, have emerged as key drivers in cancer. Upon fusion, NRG1 retains its EGF-like active domain, binds to the ERBB ligand family, and triggers intracellular signaling cascades, promoting uncontrolled cell proli...
Similar Items
-
Expert consensus on the diagnosis and treatment of RET gene fusion non‐small cell lung cancer in China
by: Xingxiang Pu, et al.
Published: (2023-11-01) -
Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
by: Huimin Yan, et al.
Published: (2022-01-01) -
Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
by: Huimin Yan, et al.
Published: (2021-10-01) -
Mutual Promotion of LAP2 and CAT2 Synergistically Regulates Plant Salt and Osmotic Stress Tolerance
by: Yu Zhang, et al.
Published: (2021-06-01) -
CD39+ Regulatory T Cells Attenuate Lipopolysaccharide-Induced Acute Lung Injury via Autophagy and the ERK/FOS Pathway
by: Cen Chen, et al.
Published: (2021-01-01)